Analysis of severe adverse effects following community-based ivermectin treatment in the Democratic Republic of Congo
Abstract Background The progress of mass, community-directed, treatment with ivermectin (CDTI) for onchocerciasis control was disrupted by severe adverse effects (SAE) in the Democratic Republic of Congo (DRC). The study aimed at determining the frequency of post-CDTI SAE as well as factors associat...
Main Authors: | Jean-Claude Makenga Bof, Daniel Muteba, Paul Mansiangi, Félicien Ilunga-Ilunga, Yves Coppieters |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-08-01
|
Series: | BMC Pharmacology and Toxicology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40360-019-0327-5 |
Similar Items
-
Review of the National Program for Onchocerciasis Control in the Democratic Republic of the Congo
by: Jean-Claude Makenga Bof, et al.
Published: (2019-06-01) -
Community Participation in and Perception of Community-Directed Treatment with Ivermectin in Kinshasa, DRC
by: Jean-Claude Makenga Bof, et al.
Published: (2019-07-01) -
Single versus Multiple Dose Ivermectin Regimen in Onchocerciasis-Infected Persons with Epilepsy Treated with Phenobarbital: A Randomized Clinical Trial in the Democratic Republic of Congo
by: Michel Mandro, et al.
Published: (2020-03-01) -
Can ivermectin mass treatments eliminate onchocerciasis in Africa?
by: M. Winnen, et al. -
High prevalence of epilepsy in onchocerciasis endemic health areas in Democratic Republic of the Congo
by: Evy Lenaerts, et al.
Published: (2018-08-01)